先端ロボット・内視鏡手術学

Medicine & Life Sciences

1. Gastrectomy 100%
2. Stomach Neoplasms 67%
3. Lymph Node Excision 43%
4. Robotics 35%
5. Rectal Neoplasms 28%
6. Stomach 26%
7. Neoplasms 25%
8. Gastrointestinal Stromal Tumors 23%
9. Dissection 20%
10. Lymph Nodes 19%
11. Carcinoma 19%
12. Neoplasm Metastasis 19%
13. Japan 18%
14. Hepatic Veins 18%
15. Chemoradiotherapy 18%
16. Laparoscopy 17%
17. Recurrence 15%
18. Esophagectomy 14%
19. Capsules 14%
20. Pancreaticoduodenectomy 14%
21. Imatinib Mesylate 13%
22. Colostomy 13%
23. Rectocele 11%
24. Drug Therapy 11%
25. Liver 11%
26. Surgeons 11%
27. Arteries 10%
28. Squamous Cell Carcinoma 10%
29. Propensity Score 10%
30. Recurrent Laryngeal Nerve 10%
31. Rectum 9%
32. Pancreatic Fistula 9%
33. Pancreatectomy 9%
34. Therapeutics 9%
35. Prolapse 9%
36. Retrospective Studies 8%
37. Paclitaxel 8%
38. Vocal Cord Paralysis 7%
39. Esophagus 7%
40. fosaprepitant 7%
41. Operative Time 7%
42. Transanal Endoscopic Surgery 7%
43. Multicenter Studies 6%
44. Meglumine 6%
45. Pathologic Constriction 6%
46. Colorectal Neoplasms 6%
47. Abdomen 6%
48. Technology 6%
49. Cohort Studies 6%
50. Computer Graphics 6%
51. Dihydrouracil Dehydrogenase (NADP) 5%
52. Aprepitant 5%
53. Pancreaticojejunostomy 5%
54. Solitary Fibrous Tumors 5%
55. Cystic Lymphangioma 5%
56. Morbidity 5%
57. Splenic Artery 5%
58. Aggressive Fibromatosis 5%
59. Survival 5%
60. Intraoperative Monitoring 5%
61. Anastomotic Leak 5%
62. Intra Arterial Infusions 5%
63. Adenoma 5%
64. Mesenteric Veins 5%
65. Margins of Excision 5%
66. Prone Position 5%